apl. Prof. Dr. Udo Gaipl

Medizinische Fakultät Department of Radiation Oncology

Differences of the immune phenotype of breast cancer cells after ex vivo hyperthermia by warm-water or microwave radiation in a closed-loop system alone or in combination with radiotherapy (2020) Hader M, Savcigil DP, Rosin A, Ponfick P, Gekle S, Wadepohl M, Bekeschus S, et al. Journal article Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, et al. Journal article, Review article Graphene Oxide Nanosheets for Localized Hyperthermia-Physicochemical Characterization, Biocompatibility, and Induction of Tumor Cell Death (2020) Podolska M, Barras A, Alexiou C, Frey B, Gaipl U, Boukherroub R, Szunerits S, et al. Journal article Is it time to redefine the role of low-dose radiotherapy for benign disease? (2020) Montero A, Sabater S, Roedel F, Gaipl U, Ott O, Seegenschmiedt MH, Arenas M Journal article, Letter Editorial: Radioimmunotherapy—Translational Opportunities and Challenges (2020) Gaipl U, Multhoff G, Pockley AG, Rödel F Journal article Combination of gas plasma and radiotherapy has immunostimulatory potential and additive toxicity in murine melanoma cells in vitro (2020) Pasqual-Melo G, Sagwal SK, Freund E, Gandhirajan RK, Frey B, von Woedtke T, Gaipl U, Bekeschus S Journal article Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials (2020) Zhou JG, Huang L, Jin SH, Xu C, Frey B, Ma H, Gaipl U Journal article, Review article Immune biological rationales for the design of combined radio- and immunotherapies (2020) Hader M, Frey B, Fietkau R, Hecht M, Gaipl U Journal article, Review article Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy (2020) Frey B, Mika J, Jelonek K, Cruz-Garcia L, Roelants C, Testard I, Cherradi N, et al. Journal article Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? (2020) Roedel F, Arenas M, Ott O, Fournier C, Georgakilas AG, Tapio S, Trott KR, Gaipl U Journal article, Review article